Effect of phenobarbital on cyclophosphamide metabolism in rats. 1976

M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini

1. The pharmacokinetics of cyclophosphamide and its alkylating metabolites have been studied in rats whose liver microsomal enzymes had been induced by phenobarbital pre-treatment. 2. Serum levels of cyclophosphamide were determined using a new g.l.c. method. The half-life of cyclophosphamide in blood of rats pre-treated with phenobarbital was shorter than in control rats. This change is closely related to higher rates of production of p-nitrobenzylpyridine-positive alkylating metabolites of cyclophosphamide, which in turn is followed by their more rapid disappearance from the circulation. 3. Urinary excretion reflects this situation; lower amounts of cyclophosphamide and higher concentrations of its alkylating metabolites are present in the urine of phenobarbital-treated rats. 4. Perfusion of livers isolated from phenobarbital-pre-treated rats confirmed the results in vivo. With this preparation, too, disappearance of cyclophosphamide was more rapid and formation of its alkylating metabolites was accelerated after phenobarbital treatment.

UI MeSH Term Description Entries
D008297 Male Males
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D000477 Alkylating Agents Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. Alkylating Agent,Alkylator,Alkylators,Agent, Alkylating,Agents, Alkylating
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
August 1976, Cancer research,
M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
April 1983, Biulleten' eksperimental'noi biologii i meditsiny,
M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
October 1973, Biochemical pharmacology,
M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
April 1984, Biochemical and biophysical research communications,
M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
December 1976, Archives of biochemistry and biophysics,
M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
March 1973, The Journal of pharmacology and experimental therapeutics,
M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
June 1989, Toxicology and applied pharmacology,
M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
January 1996, Drug metabolism and drug interactions,
M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
March 1972, The Journal of laboratory and clinical medicine,
M G Donelli, and A Guaitani, and I Bartosek, and A Bossi, and T Colombo, and S Garattini
January 1974, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!